Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentScientific writers
View the documentIntroduction
View the documentTake-home messages
Open this folder and view contentsSection I - Setting the scene
Open this folder and view contentsSection II - Improving adherence rates: guidance for countries
Close this folderSection III - Disease-Specific Reviews
Open this folder and view contentsChapter VII - Asthma
Open this folder and view contentsChapter VIII - Cancer (Palliative care)
Close this folderChapter IX - Depression
View the document1. Research methods: measurement of adherence and sampling
View the document2. Rates of adherence
View the document3. Predictors of adherence
View the document4. Interventions to improve adherence
View the document5. Clinical implications and need for further research
View the document6. References
Open this folder and view contentsChapter X - Diabetes
Open this folder and view contentsChapter XI - Epilepsy
Open this folder and view contentsChapter XII - Human immunodeficiency virus and acquired immunodeficiency syndrome
Open this folder and view contentsChapter XIII - Hypertension
Open this folder and view contentsChapter XIV - Tobacco smoking cessation
Open this folder and view contentsChapter XV - Tuberculosis
Open this folder and view contentsAnnexes
Open this folder and view contentsWhere to find a copy of this book
 

6. References

1. Murray C, Lopez A. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990. Cambridge, MA, Harvard University Press, 1996.

2. Peveler R, Kendrick A. Treatment delivery and guidelines in primary care. British Medical Bulletin, 2001, 57: 193 - 206.

3. Kroll J et al. Medication compliance, antidepressant blood levels, and side effects in Southeast Asian patients. Journal of Clinical Psychopharmacology, 1990, 10: 279 - 283.

4. George CF et al. Compliance with tricyclic antidepressants: the value of four different methods of assessment. British Journal of Clinical Pharmacology, 2000, 50: 166 - 171.

5. Peveler R et al. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. British Medical Journal, 1999, 319: 612 - 615.

6. McCombs JS et al. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. Journal of Clinical Psychiatry, 1990, 51 (Suppl): 60 - 69.

7. Katon W et al. Adequacy and duration of antidepressant treatment in primary care. Medical Care, 1992, 30: 67 - 76.

8. Lin EH et al. Low-intensity treatment of depression in primary care: is it problematic? General Hospital Psychiatry, 2000, 22: 78 - 83.

9. Schumann C et al.; Nonadherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Research, 1999, 89: 247 - 257.

10. Ramana R et al. Medication received by patients with depression following the acute episode: adequacy and relation to outcome. British Journal of Psychiatry, 1999, 174: 128 - 134.

11. Gasquet I et al. [Determinants of compliance with antidepressive drugs.] [French] Encephale, 2001, 27: 83 - 91.

12. Myers ED, Branthwaite A. Out-patient compliance with antidepressant medication. British Journal of Psychiatry, 1992, 160: 83 - 86.

13. Claxton A et al. Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder. Journal of Clinical Psychiatry, 2000, 61: 928 - 932.

14. Lin EH et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Medical Care, 1995, 33: 67 - 74.

15. Tai-Seale M, Croghan TW, Obenchain R. Determinants of antidepressant treatment compliance: implications for policy. Medical Care Research & Review, 2000, 57: 491 - 512.

16. Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. International Clinical Psychopharmacology, 1995, 9 (Suppl 4): 33 - 40.

17. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. British Medical Journal, 1995, 310: 1433 - 1438.

18. Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal of Psychiatry, 1997, 170: 120 - 127.

19. Furukawa TA, Streiner DL, Young LT. Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. Journal of Affective Disorders, 2001, 65: 173 - 177.

20. Keeley R, Smith M, Miller J. Somatoform symptoms and treatment nonadherence in depressed family medicine outpatients. Archives of Family Medicine, 2000, 9: 46 - 54.

21. Ekselius L, Bengtsson F, von Knorring L. Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality. International Clinical Psychopharmacology, 2000, 15: 273 - 278.

22. Tutty S, Simon G, Ludman E. Telephone counseling as an adjunct to antidepressant treatment in the primary care system. A pilot study. Effective Clinical Practice, 2000, 3: 170 - 178.

23. Mundt JC et al. Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education. Depression & Anxiety, 2001, 13: 1 - 10.

24. Katon W et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. Journal of the American Medical Association, 1995, 273: 1026 - 1031.

25. Katon W et al. A multifaceted intervention to improve treatment of depression in primary care. Archives of General Psychiatry, 1996, 53: 924 - 932.

26. Lin EH et al. Can enhanced acute-phase treatment of depression improve long-term outcomes? A report of randomized trials in primary care. American Journal of Psychiatry, 1999, 156: 643 - 645.

27. Katon W et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Archives of General Psychiatry, 1999, 56: 1109 - 1115.

28. Katon W et al. A randomized trial of relapse prevention of depression in primary care. Archives of General Psychiatry, 2001, 58: 241 - 247.

29. Johnson, DA. Treatment of depression in general practice. 1973, British Medical Journal. 266: 18 - 20.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014